Literature DB >> 11874775

Assessment of clinically significant changes in acute pain in children.

Blake Bulloch1, Milton Tenenbein.   

Abstract

OBJECTIVE: To quantify, using two pain assessment scales, the amount of change in pain severity required to achieve a clinically significant improvement in pain in children presenting to a pediatric emergency department (ED) with pain.
METHODS: Prospective, descriptive study involving all children presenting to a pediatric ED between 5 and 16 years of age inclusive with acute pain. Children were excluded if they 1) were intoxicated or had altered sensorium, 2) were clinically unstable, 3) were non-English-speaking, or 4) were developmentally delayed. Written informed consent was obtained. Children were asked to mark their current pain severity on the standardized Color Analogue Scale (CAS) and Faces Pain Scale (FPS). After each pain control intervention the child was asked to repeat these measurements and to describe whether his or her pain was "much less," "a little less," "about the same," "a little worse," or "much worse" compared with before. This process was repeated until the child was discharged from the ED or had a score of zero. The main outcome measure was the smallest change on the CAS or FPS necessary to cause the child to describe his or her pain as a "little less." This was defined as the clinically significant change in pain. The "ideal" change in pain was defined as the amount of change necessary for the child to describe the pain as "much less" or at which point the child thought he or she no longer required any medicine to help the pain go away.
RESULTS: One hundred twenty-one children were enrolled with a mean age of 9.8 years (SD +/- 3.15). Males accounted for 56%. Pain was traumatic in 65% and nontraumatic in 35%. A total of 153 pain comparisons were made using the CAS and 154 using the FPS. Only three children complained that their pain got worse (two a little worse and one much worse). Pain was described as "the same" in 20. Of the 60 pain comparisons judged to be a "little less," the CAS score changed by a median of 2.0 cm [interquartile ratio (IQR) 1-3], and the FPS by 1.0 face (IQR 1-2). In the 71 children who judged their pain to be "much less," the CAS decreased by a median of 4.0 cm (IQR 2-5) and the FPS by 2.0 faces (IQR 2-3).
CONCLUSIONS: The assessment and treatment of pain in children are an important component of pediatric practice, especially in the ED. This study provides health care professionals and clinical investigators the information necessary to assess whether their method of pain control in children is clinically relevant.

Entities:  

Mesh:

Year:  2002        PMID: 11874775     DOI: 10.1111/j.1553-2712.2002.tb00244.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  10 in total

1.  Changes in Pain Score Associated With Clinically Meaningful Outcomes in Children With Acute Pain.

Authors:  Daniel S Tsze; Gerrit Hirschfeld; Carl L von Baeyer; Leonor E Suarez; Peter S Dayan
Journal:  Acad Emerg Med       Date:  2019-02-19       Impact factor: 3.451

2.  Gender differences in acute and chronic pain in the emergency department: results of the 2014 Academic Emergency Medicine consensus conference pain section.

Authors:  Paul I Musey; Sarah D Linnstaedt; Timothy F Platts-Mills; James R Miner; Andrey V Bortsov; Basmah Safdar; Polly Bijur; Alex Rosenau; Daniel S Tsze; Andrew K Chang; Suprina Dorai; Kirsten G Engel; James A Feldman; Angela M Fusaro; David C Lee; Mark Rosenberg; Francis J Keefe; David A Peak; Catherine S Nam; Roma G Patel; Roger B Fillingim; Samuel A McLean
Journal:  Acad Emerg Med       Date:  2014-11-24       Impact factor: 3.451

3.  Clinically significant differences in acute pain measured on self-report pain scales in children.

Authors:  Daniel S Tsze; Gerrit Hirschfeld; Carl L von Baeyer; Blake Bulloch; Peter S Dayan
Journal:  Acad Emerg Med       Date:  2015-03-13       Impact factor: 3.451

4.  Clinically meaningful measurement of pain in children with sickle cell disease.

Authors:  Matthew P Myrvik; Amanda M Brandow; Amy L Drendel; Ke Yan; Raymond G Hoffmann; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2013-06-17       Impact factor: 3.167

5.  Oral morphine versus ibuprofen administered at home for postoperative orthopedic pain in children: a randomized controlled trial.

Authors:  Naveen Poonai; Natasha Datoo; Samina Ali; Megan Cashin; Amy L Drendel; Rongbo Zhu; Natasha Lepore; Michael Greff; Michael Rieder; Debra Bartley
Journal:  CMAJ       Date:  2017-10-10       Impact factor: 8.262

Review 6.  Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain.

Authors:  Mette Frahm Olsen; Eik Bjerre; Maria Damkjær Hansen; Jørgen Hilden; Nino Emanuel Landler; Britta Tendal; Asbjørn Hróbjartsson
Journal:  BMC Med       Date:  2017-02-20       Impact factor: 8.775

7.  Pre-hospital intranasal analgesia for children suffering pain: a rapid evidence review.

Authors:  Gregory Adam Whitley; Richard Pilbery
Journal:  Br Paramed J       Date:  2019-12-01

Review 8.  The effectiveness and safety of paediatric prehospital pain management: a systematic review.

Authors:  Yonas Abebe; Fredrik Hetmann; Kacper Sumera; Matt Holland; Trine Staff
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-12-11       Impact factor: 2.953

9.  The predictors, barriers and facilitators to effective management of acute pain in children by emergency medical services: A systematic mixed studies review.

Authors:  Gregory A Whitley; Pippa Hemingway; Graham R Law; Arwel W Jones; Ffion Curtis; Aloysius N Siriwardena
Journal:  J Child Health Care       Date:  2020-08-26       Impact factor: 1.979

10.  Study protocol of a randomised controlled trial of intranasal ketamine compared with intranasal fentanyl for analgesia in children with suspected, isolated extremity fractures in the paediatric emergency department.

Authors:  Stacy L Reynolds; Jonathan R Studnek; Kathleen Bryant; Kelly VanderHave; Eric Grossman; Charity G Moore; James Young; Melanie Hogg; Michael S Runyon
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.